The Albany International Airport has completed the first phase of its Concourse A Rehabilitation Project. Phase one included ...

Lilly’s orforglipron cut body weight as expected in the Phase III ATTAIN-1 trial, but to a lesser extent than rival Novo ...

Quantum Biopharma Ltd. (NASDAQ:QNTM) announced on Tuesday that its subsidiary Huge Biopharma Australia has received the ...

VALORANT’s Esports Product Manager has revealed a list of tournaments which will offer direct qualification to Project ...

It looks likely we'll see oral GLP-1 drugs on the market by next year, with pharmaceutical company Eli Lilly reporting ...

Hemispherian's GLIX1 gains FDA approval for glioblastoma trials, promising a novel therapy targeting DNA repair in tumor ...

Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...

The Pension Fund Regulatory and Development Authority has published 40 vacancies for the recruitment of Officer Grade ‘A’ ...

Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.

A new leak has revealed the character banner lineup for Genshin Impact 6.0, including characters who will rerun alongside the ...

The Telangana Council of Higher Education (TGCHE) has officially commenced the TS/TG LAWCET 2025 counselling registration ...

Luye Pharma Group today announced that the first subject has been enrolled in a Phase 1 clinical trial in China for its LY03021, which was filed through China's Class 1 pathway for innovative drugs.